Naftidrofuryl
From Wikipedia, the free encyclopedia
Naftidrofuryl
|
|
Systematic (IUPAC) name | |
2-diethylaminoethyl 2-(naphthalen-1-ylmethyl)- 3-(oxolan-2-yl)propanoate |
|
Identifiers | |
CAS number | |
ATC code | C04 |
PubChem | |
Chemical data | |
Formula | C24H33NO3 |
Mol. mass | 383.524 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Naftidrofuryl (INN, also known as nafronyl or as the oxalate salt nafronyl oxalate) is a drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic.[1] It may also be a 5-HT2 receptor antagonist.
[edit] References
- ^ Reynolds, J.E.F. (ed.) (1993). Martindale: The extra pharmacopoeia, 30th edition, London: Pharmaceutical Press, p. 1310. ISBN 0853693005.
|